SPC295

Darólútamíð, valkvætt á formi lyfjafræðilega viðunandi salts eða esters þar af

  • Status:
    Veitt
  • Application date:
    14.5.2020
  • Application published:
    15.6.2020
  • Grant published:
    15.4.2021
  • Max expiry date:
    29.3.2035
  • Medicine name:
    Nubeqa
  • Medicine for children:
    No

Timeline

Today
14.5.2020Application
15.6.2020Publication
15.4.2021Registration
29.3.2035Expires

Marketing license

  • IS authorization number:
    EU/1/20/1432/001
  • Date:
    17.4.2020
  • Foreign authorization number:
    EU/1/20/1432
  • Date:
    27.3.2020

Owner

  • Name:
    Orion Corporation
  • Address:
    Orionintie 1, Espoo FI

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents